Included in the formulation
АТХ:G.04.C.X.03 Mepartarticine
G.04.C.X Other drugs for the treatment of benign prostatic hyperplasia
Pharmacodynamics:The drug has an antidisuric effect and normalizes the functions of the prostate by improving passage of urine in adenoma. Reduces the urge to urinate and the amount of residual urine.
Pharmacokinetics:Irreversibly binds sterols in the gastrointestinal tract, when ingested it is not absorbed and does not penetrate into the systemic bloodstream.
Indications:Functional disorders of urination with benign prostatic hyperplasia.
XIV.N40-N51.N40 Hyperplasia of the prostate
Contraindications:Individual intolerance.
Pregnancy and lactation:Not assigned to women.
Dosing and Administration:It is recommended to take during supper, 40 mg for 30 days (if necessary, the course can be increased).
Side effects:Pain in the stomach, nausea, vomiting, diarrhea.
Interaction:Slows the absorption of other drugs in gastrointestinal tract when used together.
Special instructions:Do not shorten the course of treatment, even with a rapid improvement in the condition.